尼古丁酸 (NA) 通过促进海马中神经保护性转录组促进抗抑郁作用
Yikai Chen1, Wen Ye1, Wenxin Wang1
1Center for Precision Medicine, School of Medicine, Huaqiao University, Xiamen, 361021, China.
Pharmacology, biochemistry, and behavior
|December 31, 2025
概括
尼古丁酸 (NA) 是NAD+的前体,在小鼠中减少了类似抑郁症的行为. 此外,NA疗法还恢复了海马体基因网络和代谢平衡,表明其作为新型抗抑郁药的潜力.
科学领域:
- 神经科学是一个神经科学.
- 代谢精神病学 代谢精神病学
背景情况:
- 大型抑郁症 (MDD) 涉及无情和认知缺陷.
- 慢性压力模型对于理解MDD病理生理学至关重要.
- 尼古丁胺胺氨基二核酸 (NAD+) 在细胞代谢和神经元功能中起作用.
研究的目的:
- 为了研究尼古丁酸 (NA),一个NAD+前体的抗抑郁作用.
- 在小鼠模型中探索NA对压力诱导的行为和分子变化的影响.
主要方法:
- 利用慢性克制压力 (CRS) 鼠标模型来诱导类似抑郁的行为.
- 给出的尼古丁酸 (NA) 和评估的行为结果 (糖糖偏好,强迫游泳测试,尾部悬浮测试,旋杆测试).
- 进行海马体转录组分析以确定分子机制.
主要成果:
- 在CRS模型中,NA治疗显著改善了类似抑郁的行为.
- 在行为测试中,NA恢复了糖偏好和减少了不动.
- 海马体转录组学揭示了NA逆转了压力诱导的基因失调,激活了神经保护通路 (Wnt/β-catenin,cGMP-PKG,cAMP),并使脂质/氨酸代谢正常化.
结论:
- 尼古丁酸 (NA) 在慢性压力小鼠模型中表现出类似抗抑郁药的效果.
- 通过增强突触可塑性和通过海马体基因网络重塑恢复代谢平衡,NA可能会发挥作用.
- 作为一种代谢性抗抑郁药,NA显示出承诺,支持基于NAD+前体的情绪障碍疗法.
相关概念视频
01:30Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
503
Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.
503
01:23Antidepressant Drugs: MAOIs and Other Agents
765
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
765
01:25Antidepressant Drugs: Overview
1.3K
Antidepressant drugs are a class of medications primarily used for treating various mood disorders, including major depression, anxiety disorders, and other related conditions. These medicines work by modulating the neurotransmitter balance within the brain, alleviating depressive symptoms. Antidepressants can be broadly categorized into several groups according to their mechanism of action and chemical structure: Selective Serotonin Reuptake Inhibitors (SSRIs), Serotonin-Norepinephrine...
1.3K
01:29Drugs Affecting Neurotransmitter Synthesis
2.1K
Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase,...
2.1K
01:22Alzheimer's Disease: Treatment
744
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
744
01:28Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs
1.3K
Tricyclic Antidepressants (TCAs), including Desipramine (Norpramin), Imipramine (Tofranil), Clomipramine (Anafranil), and Amitriptyline (Elavil), inhibit serotonin and norepinephrine reuptake and also block other receptors. They are used for depression, pain conditions, and insomnia. Common adverse effects include anticholinergic effects, sedation, orthostatic hypotension, and weight gain. They have a narrow therapeutic window and so require plasma-level monitoring. Abrupt discontinuation can...
1.3K